关注
Francesco Ciccarese
Francesco Ciccarese
Istituto Oncologico Veneto IOV-IRCCS
在 iov.veneto.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Oncogenic pathways and the electron transport chain: a dangeROS liaison
V Raimondi, F Ciccarese, V Ciminale
British journal of cancer 122 (2), 168-181, 2020
1442020
Escaping death: mitochondrial redox homeostasis in cancer cells
F Ciccarese, V Ciminale
Frontiers in oncology 7, 117, 2017
1032017
LKB1/AMPK pathway and drug response in cancer: a therapeutic perspective
F Ciccarese, E Zulato, S Indraccolo
Oxidative medicine and cellular longevity 2019 (1), 8730816, 2019
1002019
The miR-200 family of microRNAs: fine tuners of epithelial-mesenchymal transition and circulating cancer biomarkers
I Cavallari, F Ciccarese, E Sharova, L Urso, V Raimondi, M Silic-Benussi, ...
Cancers 13 (23), 5874, 2021
872021
VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells
M Curtarello, E Zulato, G Nardo, S Valtorta, G Guzzo, E Rossi, G Esposito, ...
Cancer research 75 (1), 120-133, 2015
712015
Nanoparticles as tools to target redox homeostasis in cancer cells
F Ciccarese, V Raimondi, E Sharova, M Silic-Benussi, V Ciminale
Antioxidants 9 (3), 211, 2020
482020
LKB1 expression correlates with increased survival in patients with advanced non–small cell lung cancer treated with chemotherapy and bevacizumab
L Bonanno, A De Paoli, E Zulato, G Esposito, F Calabrese, A Favaretto, ...
Clinical Cancer Research 23 (13), 3316-3324, 2017
472017
LKB1 loss is associated with glutathione deficiency under oxidative stress and sensitivity of cancer cells to cytotoxic drugs and γ-irradiation
E Zulato, F Ciccarese, V Agnusdei, M Pinazza, G Nardo, E Iorio, ...
Biochemical pharmacology 156, 479-490, 2018
412018
Metabolic rewiring and redox alterations in malignant pleural mesothelioma
L Urso, I Cavallari, E Sharova, F Ciccarese, G Pasello, V Ciminale
British journal of cancer 122 (1), 52-61, 2020
282020
Contribution of the residue at position 4 within classical nuclear localization signals to modulating interaction with importins and nuclear targeting
KM Smith, V Di Antonio, L Bellucci, DR Thomas, F Caporuscio, ...
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1865 (8), 1114-1129, 2018
282018
mTOR inhibition downregulates glucose-6-phosphate dehydrogenase and induces ROS-dependent death in T-cell acute lymphoblastic leukemia cells
M Silic-Benussi, E Sharova, F Ciccarese, I Cavallari, V Raimondi, L Urso, ...
Redox biology 51, 102268, 2022
202022
Hepatitis C virus and host cell nuclear transport machinery: a clandestine affair
B Bonamassa, F Ciccarese, VD Antonio, A Contarini, G Palù, G Alvisi
Frontiers in Microbiology 6, 619, 2015
192015
Comprehensive profiling of hypoxia-related miRNAs identifies miR-23a-3p overexpression as a marker of platinum resistance and poor prognosis in high-grade serous ovarian cancer
P Todeschini, E Salviato, C Romani, V Raimondi, F Ciccarese, F Ferrari, ...
Cancers 13 (13), 3358, 2021
122021
Involvement of NADPH oxidase 1 in liver kinase B1-mediated effects on tumor angiogenesis and growth
E Zulato, F Ciccarese, G Nardo, M Pinazza, V Agnusdei, M Silic-Benussi, ...
Frontiers in oncology 8, 195, 2018
112018
2-hydroxyglutarate in acute myeloid leukemia: a journey from pathogenesis to therapies
V Raimondi, G Ciotti, M Gottardi, F Ciccarese
Biomedicines 10 (6), 1359, 2022
92022
Genetic perturbation of IFN-α transcriptional modulators in human endothelial cells uncovers pivotal regulators of angiogenesis
F Ciccarese, A Grassi, L Pasqualini, S Rosano, A Noghero, F Montenegro, ...
Computational and Structural Biotechnology Journal 18, 3977-3986, 2020
72020
Generation of combinatorial lentiviral vectors expressing multiple anti-hepatitis C virus shRNAs and their validation on a novel HCV replicon double reporter cell line
HM Elbadawy, MI Mohammed Abdul, N Aljuhani, A Vitiello, F Ciccarese, ...
Viruses 12 (9), 1044, 2020
62020
Reconstruction of gene regulatory modules from RNA silencing of IFN-α modulators: experimental set-up and inference method
A Grassi, B Di Camillo, F Ciccarese, V Agnusdei, P Zanovello, A Amadori, ...
BMC genomics 17, 1-10, 2016
32016
Cancer Metabolism and Resistance to Cell Death: Novel Therapeutic Perspectives
F Ciccarese
Biomedicines 10 (8), 1828, 2022
22022
Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomas
J Choi, M Ceribelli, JD Phelan, B Häupl, GW Wright, T Hsiao, V Morris, ...
Cancer cell 42 (5), 833-849. e12, 2024
12024
系统目前无法执行此操作,请稍后再试。
文章 1–20